OLMA
Olema Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $753.35M
- Employees
- 137
- Latest publication
- 2026-09-29
About Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic ER-positive, human epidermal growth factor receptor 2-negative breast cancer; OPERA-01, the pivotal Phase 3 clinical trial of palazestrant as a monotherapy in second/third-line ER+/HER2- metastatic breast cancer; and palazestrant with CDK4/6 inhibitors, a phosphatidylinositol 3 kinase alpha (PI3Ka) inhibitor alpelisib, a mechanistic target of rapamycin inhibitor, and a CDK4 inhibitor that is in Phase 1b/2 clinical trial for the treatment of ER+/HER2- advanced or metastatic breast cancer. It also develops OP-3136, an orally-available small molecule that potently and selectively inhibits KAT6 which is in Phase 1 clinical trials for patients with breast and other solid tumor cancers. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 364,000USD | 0USD | 0USD |
| Cost Of Revenue | 119,000USD | 187,000USD | — | — | 128,000USD | 182,000USD | 95,000USD | 94,000USD |
| Gross Profit | -119,000USD | -187,000USD | — | — | -128,000USD | 182,000USD | -95,000USD | -94,000USD |
| Research Development | 49,232,000USD | 43,220,000USD | 39,951,000USD | 43,902,000USD | 30,624,000USD | 32,299,000USD | 33,226,000USD | 29,109,000USD |
| Selling General Administrative | 8,754,000USD | 6,864,000USD | 5,926,000USD | 3,962,000USD | 4,249,000USD | 4,469,000USD | 4,395,000USD | 4,421,000USD |
| Selling And Marketing Expenses | 119,000USD | — | — | — | — | — | — | 94,000USD |
| Total Operating Expenses | 57,867,000USD | 49,897,000USD | 45,877,000USD | 47,864,000USD | 34,873,000USD | 36,768,000USD | 37,621,000USD | 33,530,000USD |
| Operating Income | -57,986,000USD | -50,084,000USD | -45,877,000USD | -47,864,000USD | -34,873,000USD | -36,768,000USD | -37,621,000USD | -33,530,000USD |
| Interest Income | 4,776,000USD | 4,010,000USD | 3,648,000USD | 4,042,000USD | 4,524,000USD | 3,294,000USD | 2,928,000USD | 3,108,000USD |
| Net Interest Income | 4,776,000USD | 4,010,000USD | 3,648,000USD | 4,042,000USD | 4,524,000USD | 3,294,000USD | 2,928,000USD | 3,108,000USD |
| Income Before Tax | -53,089,000USD | -46,061,000USD | -42,217,000USD | -43,784,000USD | -30,389,000USD | -33,567,000USD | -34,555,000USD | -30,382,000USD |
| Net Income | -53,089,000USD | -46,061,000USD | -42,217,000USD | -43,784,000USD | -30,389,000USD | -33,567,000USD | -34,555,000USD | -30,382,000USD |
| Net Income From Continuing Ops | -53,089,000USD | -46,061,000USD | -42,217,000USD | -43,784,000USD | -30,389,000USD | -33,567,000USD | -34,555,000USD | -30,382,000USD |
| Ebit | -57,986,000USD | -50,084,000USD | -42,217,000USD | -47,864,000USD | -34,873,000USD | -36,768,000USD | -37,621,000USD | -33,530,000USD |
| Ebitda | -57,867,000USD | -49,897,000USD | -42,174,000USD | -47,732,000USD | -34,745,000USD | -36,652,000USD | -37,526,000USD | -33,436,000USD |
| Depreciation And Amortization | 119,000USD | 187,000USD | 43,000USD | 132,000USD | 128,000USD | 116,000USD | 95,000USD | 94,000USD |
| Reconciled Depreciation | 119,000USD | 187,000USD | 43,000USD | 132,000USD | 128,000USD | 116,000USD | 95,000USD | 94,000USD |
| Total Other Income Expense Net | 4,897,000USD | 4,023,000USD | 3,660,000USD | 4,080,000USD | 4,484,000USD | 3,201,000USD | 3,066,000USD | 3,148,000USD |
| Income Tax Expense | — | — | — | — | — | 3,352,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 157,697,000USD | 124,517,000USD | 86,140,000USD | 82,274,000USD | 51,100,000USD | 13,704,000USD | 3,920,000USD | 1,693,000USD |
| Selling General Administrative | 21,001,000USD | 17,741,000USD | 18,821,000USD | 24,714,000USD | 20,391,000USD | 7,824,000USD | 403,000USD | 386,000USD |
| Total Operating Expenses | 178,698,000USD | 142,258,000USD | 104,961,000USD | 106,988,000USD | 71,491,000USD | 21,517,000USD | 4,323,000USD | 2,079,000USD |
| Operating Income | -178,698,000USD | -142,258,000USD | -104,961,000USD | -106,988,000USD | -71,491,000USD | -21,528,000USD | -4,323,000USD | -2,079,000USD |
| Interest Income | 16,224,000USD | 12,682,000USD | 5,747,000USD | 2,228,000USD | 442,000USD | 60,000USD | 7,000USD | 4,000USD |
| Net Interest Income | 16,224,000USD | 12,682,000USD | 5,747,000USD | 2,228,000USD | 442,000USD | -593,000USD | 7,000USD | -24,000USD |
| Income Before Tax | -162,451,000USD | -129,474,000USD | -96,655,000USD | -104,787,000USD | -71,096,000USD | -22,121,000USD | -4,316,000USD | -2,197,000USD |
| Net Income | -162,451,000USD | -129,474,000USD | -96,655,000USD | -102,586,000USD | -71,096,000USD | -22,121,000USD | -4,316,000USD | -2,197,000USD |
| Net Income From Continuing Ops | -162,451,000USD | -129,474,000USD | -96,062,000USD | -104,787,000USD | -71,096,000USD | -22,121,000USD | -4,316,000USD | -2,197,000USD |
| Ebit | -178,698,000USD | -142,258,000USD | -104,961,000USD | -106,988,000USD | -71,491,000USD | -21,528,000USD | -4,316,000USD | -2,169,000USD |
| Ebitda | -178,208,000USD | -141,865,000USD | -104,584,000USD | -106,631,000USD | -71,328,000USD | -21,517,000USD | -4,306,967USD | -2,160,756USD |
| Depreciation And Amortization | 490,000USD | 393,000USD | 377,000USD | 357,000USD | 163,000USD | 11,000USD | 9,033USD | 8,244USD |
| Reconciled Depreciation | 490,000USD | 393,000USD | 386,000USD | 357,000USD | 163,000USD | 11,000USD | 9,000USD | 8,000USD |
| Total Other Income Expense Net | 16,247,000USD | 12,784,000USD | 8,306,000USD | 2,201,000USD | 395,000USD | -593,000USD | 7,000USD | -118,000USD |
| Cost Of Revenue | — | 393,000USD | 377,000USD | 1,658,000USD | 1,663,000USD | 11,000USD | 9,033USD | 8,244USD |
| Gross Profit | — | -393,000USD | -377,000USD | -1,658,000USD | -1,663,000USD | -11,000USD | -9,033USD | -8,244USD |
| Income Tax Expense | — | -1USD | — | -2,201,000USD | -210,000USD | 642,000USD | -155,860USD | -90,000USD |
| Selling And Marketing Expenses | — | — | 377,000USD | — | — | — | — | — |
| Interest Expense | — | — | — | 357,000USD | 232,000USD | 653,000USD | 0USD | 28,000USD |
| Non Operating Income Net Other | — | — | — | 2,201,000USD | 395,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -104,787,000USD | -71,096,000USD | -23,990,000USD | -4,316,000USD | -2,197,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 530,645,000USD | 533,430,000USD | 352,453,000USD | 382,002,000USD | 409,639,000USD | 450,979,000USD | 230,173,000USD | 254,557,000USD |
| Other Current Assets | 7,882,000USD | 5,959,000USD | 2,398,000USD | 3,066,000USD | 2,036,000USD | 2,267,000USD | 2,544,000USD | 2,262,000USD |
| Total Liab | 50,167,000USD | 54,871,000USD | 44,965,000USD | 36,766,000USD | 26,187,000USD | 42,015,000USD | 31,262,000USD | 27,394,000USD |
| Total Stockholder Equity | 480,478,000USD | 478,559,000USD | 307,488,000USD | 345,236,000USD | 383,452,000USD | 408,964,000USD | 198,911,000USD | 227,163,000USD |
| Other Current Liab | 42,492,000USD | 41,425,000USD | 37,013,000USD | 31,077,000USD | 24,888,000USD | 36,085,000USD | 26,806,000USD | 21,017,000USD |
| Common Stock | 8,000USD | 8,000USD | 7,000USD | 7,000USD | 7,000USD | 6,000USD | 4,000USD | 4,000USD |
| Capital Stock | 8,000USD | 8,000USD | 7,000USD | 7,000USD | 7,000USD | 6,000USD | 4,000USD | 4,000USD |
| Retained Earnings | -650,646,000USD | -597,557,000USD | -551,496,000USD | -509,279,000USD | -465,495,000USD | -435,106,000USD | -401,539,000USD | -366,984,000USD |
| Cash | 52,547,000USD | 48,301,000USD | 35,260,000USD | 52,473,000USD | 50,640,000USD | 139,480,000USD | 35,888,000USD | 16,892,000USD |
| Cash And Short Term Investments | 505,347,000USD | 505,437,000USD | 328,960,000USD | 361,913,000USD | 392,707,000USD | 434,086,000USD | 214,763,000USD | 239,104,000USD |
| Total Current Assets | 513,229,000USD | 515,452,000USD | 334,329,000USD | 367,725,000USD | 396,663,000USD | 438,473,000USD | 217,994,000USD | 242,187,000USD |
| Total Current Liabilities | 47,167,000USD | 51,802,000USD | 41,655,000USD | 33,164,000USD | 26,064,000USD | 41,758,000USD | 30,700,000USD | 26,535,000USD |
| Net Debt | -51,591,000USD | -47,108,000USD | -30,782,000USD | -47,718,000USD | -49,492,000USD | -138,051,000USD | -34,189,000USD | -14,930,000USD |
| Short Term Debt | 956,000USD | 1,124,000USD | 1,168,000USD | 1,153,000USD | 1,025,000USD | 1,172,000USD | 1,137,000USD | 1,103,000USD |
| Short Long Term Debt Total | 956,000USD | 1,193,000USD | 4,478,000USD | 4,755,000USD | 1,148,000USD | 1,429,000USD | 1,699,000USD | 1,962,000USD |
| Long Term Debt | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | — | — | — | — |
| Short Term Investments | 452,800,000USD | 457,136,000USD | 293,700,000USD | 309,440,000USD | 342,067,000USD | 294,606,000USD | 178,875,000USD | 222,212,000USD |
| Accounts Payable | 3,719,000USD | 9,253,000USD | 3,474,000USD | 934,000USD | 151,000USD | 4,460,000USD | 2,685,000USD | 4,354,000USD |
| Property Plant Equipment Net | 921,000USD | 1,146,000USD | 1,905,000USD | 2,245,000USD | 1,708,000USD | 2,060,000USD | 2,416,000USD | 2,759,000USD |
| Property Plant Equipment Gross | 1,277,000USD | 1,420,000USD | 1,905,000USD | 2,245,000USD | 1,708,000USD | 2,060,000USD | 2,416,000USD | 2,759,000USD |
| Accumulated Other Comprehensive Income | -460,000USD | 621,000USD | 526,000USD | 314,000USD | 420,000USD | 143,000USD | 464,000USD | -118,000USD |
| Common Stock Shares Outstanding | 102,800,098shares | 91,317,496shares | 85,732,221shares | 85,497,426shares | 85,426,223shares | 58,743,522shares | 57,262,803shares | 56,282,402shares |
| Non Current Assets Total | 17,416,000USD | 17,978,000USD | 18,124,000USD | 14,277,000USD | 12,976,000USD | 12,506,000USD | 12,179,000USD | 12,370,000USD |
| Non Current Liabilities Total | 3,000,000USD | 3,069,000USD | 3,310,000USD | 3,602,000USD | 123,000USD | 257,000USD | 562,000USD | 859,000USD |
| Non Currrent Assets Other | 16,495,000USD | 16,832,000USD | 16,219,000USD | 12,032,000USD | 10,529,000USD | 9,763,000USD | 9,763,000USD | 9,611,000USD |
| Net Working Capital | 466,062,000USD | 463,650,000USD | 292,674,000USD | 334,561,000USD | 370,599,000USD | 396,715,000USD | 187,294,000USD | 215,652,000USD |
| Unclassified Equity | 1,131,568,000USD | 1,075,479,000USD | 858,444,000USD | 854,187,000USD | 848,513,000USD | 843,915,000USD | 599,978,000USD | 594,257,000USD |
| Net Receivables | — | 4,056,000USD | 2,971,000USD | 2,746,000USD | 1,920,000USD | 2,120,000USD | 687,000USD | 821,000USD |
| Intangible Assets | — | — | — | 801,000USD | 739,000USD | 683,000USD | — | — |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 14,520,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -14,459,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 533,430,000USD | 450,979,000USD | 276,945,000USD | 215,645,000USD | 295,945,000USD | 342,722,000USD | 132,000USD | 3,271,000USD |
| Other Current Assets | 5,959,000USD | 2,267,000USD | 4,033,000USD | 4,159,000USD | 3,305,000USD | 3,588,000USD | 35,000USD | 93,000USD |
| Total Liab | 54,871,000USD | 42,015,000USD | 23,050,000USD | 18,099,000USD | 11,377,000USD | 4,585,000USD | 10,726,000USD | 9,549,000USD |
| Total Stockholder Equity | 478,559,000USD | 408,964,000USD | 253,895,000USD | 197,546,000USD | 284,568,000USD | 338,137,000USD | -10,594,000USD | -6,278,000USD |
| Other Current Liab | 41,425,000USD | 36,085,000USD | 17,862,000USD | 15,092,000USD | 7,977,000USD | 3,224,000USD | 443,000USD | 85,000USD |
| Common Stock | 8,000USD | 6,000USD | 4,000USD | 3,000USD | 3,000USD | 3,000USD | 1,000USD | 1,000USD |
| Capital Stock | 8,000USD | 6,000USD | 4,000USD | 3,000USD | 3,000USD | 3,000USD | 0USD | 0USD |
| Retained Earnings | -597,557,000USD | -435,106,000USD | -305,632,000USD | -208,977,000USD | -104,190,000USD | -33,094,000USD | -10,762,000USD | -6,446,000USD |
| Cash | 48,301,000USD | 139,480,000USD | 68,539,000USD | 23,702,000USD | 13,812,000USD | 338,549,000USD | 68,000USD | 3,149,000USD |
| Cash And Short Term Investments | 505,437,000USD | 434,086,000USD | 261,807,000USD | 204,421,000USD | 287,250,000USD | 338,549,000USD | 68,000USD | 3,149,000USD |
| Total Current Assets | 515,452,000USD | 438,473,000USD | 266,513,000USD | 208,899,000USD | 290,685,000USD | 342,137,000USD | 103,000USD | 3,242,000USD |
| Total Current Liabilities | 51,802,000USD | 41,758,000USD | 21,621,000USD | 16,549,000USD | 9,019,000USD | 4,585,000USD | 1,378,000USD | 201,000USD |
| Net Debt | -47,108,000USD | -138,051,000USD | -66,122,000USD | -21,137,000USD | -10,523,000USD | -338,549,000USD | -68,000USD | -3,149,000USD |
| Short Term Debt | 1,124,000USD | 1,172,000USD | 988,000USD | 1,015,000USD | 931,000USD | — | — | — |
| Short Long Term Debt Total | 1,193,000USD | 1,429,000USD | 2,417,000USD | 2,565,000USD | 3,289,000USD | — | — | — |
| Long Term Debt | 3,000,000USD | — | — | — | — | — | — | — |
| Short Term Investments | 457,136,000USD | 294,606,000USD | 193,268,000USD | 180,719,000USD | 273,438,000USD | 0USD | — | — |
| Net Receivables | 4,056,000USD | 2,120,000USD | 673,000USD | 319,000USD | 130,000USD | — | — | — |
| Accounts Payable | 9,253,000USD | 4,460,000USD | 2,698,000USD | 374,000USD | 23,000USD | 719,000USD | 935,000USD | 116,000USD |
| Property Plant Equipment Net | 1,146,000USD | 2,060,000USD | 3,259,000USD | 3,975,000USD | 4,720,000USD | 75,000USD | 26,000USD | 26,000USD |
| Property Plant Equipment Gross | 1,420,000USD | 2,060,000USD | 3,259,000USD | 4,556,000USD | 4,944,000USD | 75,000USD | 26,000USD | 26,000USD |
| Accumulated Other Comprehensive Income | 621,000USD | 143,000USD | 347,000USD | -1,813,000USD | -149,000USD | 0USD | -80,000USD | -71,000USD |
| Common Stock Shares Outstanding | 87,006,027shares | 58,743,522shares | 45,247,098shares | 39,995,460shares | 39,524,272shares | 39,308,238shares | 40,169,738shares | 14,098,571shares |
| Non Current Assets Total | 17,978,000USD | 12,506,000USD | 10,432,000USD | 6,746,000USD | 5,260,000USD | 585,000USD | 29,000USD | 29,000USD |
| Non Current Liabilities Total | 3,069,000USD | 257,000USD | 1,429,000USD | 1,550,000USD | 2,358,000USD | 719,000USD | 9,348,000USD | 9,348,000USD |
| Non Currrent Assets Other | 16,832,000USD | 9,763,000USD | 7,173,000USD | 2,771,000USD | 540,000USD | 510,000USD | 3,000USD | 3,000USD |
| Net Working Capital | 463,650,000USD | 396,715,000USD | 244,892,000USD | 192,350,000USD | 281,666,000USD | 337,552,000USD | -1,275,000USD | 3,041,000USD |
| Unclassified Equity | 1,075,479,000USD | 843,915,000USD | 559,172,000USD | 408,330,000USD | 388,901,000USD | 371,225,000USD | — | — |
| Intangible Assets | — | 683,000USD | — | — | — | — | — | — |
| Inventory | — | -4,021,000USD | — | -319,000USD | -353,000USD | — | — | — |
| Other Assets | — | — | 1USD | 2,771,000USD | 540,000USD | 342,379,788USD | 3,000USD | 3,000USD |
| Unclassified Non Current Liabilities | — | — | 1,429,000USD | — | — | — | 9,348,000USD | 9,348,000USD |
| Non Current Liabilities Other | — | — | — | 1,550,000USD | 2,358,000USD | — | — | — |
| Net Tangible Assets | — | — | — | 197,546,000USD | 284,568,000USD | 338,137,000USD | -10,594,000USD | -6,278,000USD |
| Unclassified Non Current Assets | — | — | — | -2,771,000USD | — | -342,379,788USD | — | — |
| Current Deferred Revenue | — | — | — | — | 7,687,000USD | — | — | — |
| Unclassified Current Liabilities | — | — | — | — | -7,599,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -53,089,000USD | -46,061,000USD | -42,217,000USD | -43,784,000USD | -30,389,000USD | -33,567,000USD | -34,555,000USD | -30,382,000USD |
| Depreciation | 119,000USD | 187,000USD | 43,000USD | 132,000USD | 128,000USD | 116,000USD | 95,000USD | 94,000USD |
| Stock Based Compensation | 10,148,000USD | 4,266,000USD | 4,250,000USD | 4,692,000USD | 4,378,000USD | 6,323,000USD | 5,626,000USD | 5,724,000USD |
| Other Non Cash Items | 9,176,000USD | -855,999USD | -1,021,000USD | -1,425,000USD | -1,814,000USD | -1,332,000USD | -1,713,000USD | -1,904,000USD |
| Change In Working Capital | -2,193,000USD | 4,136,999USD | 4,418,000USD | 10,502,000USD | -16,282,000USD | 2,176,000USD | 3,531,000USD | -1,087,000USD |
| Total Cash From Operating Activities | -45,987,000USD | -38,327,000USD | -34,527,000USD | -29,883,000USD | -43,979,000USD | -26,284,000USD | -27,016,000USD | -27,555,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | -159,000USD | -6,000USD |
| Free Cash Flow | -45,987,000USD | -38,327,000USD | -34,527,000USD | -29,883,000USD | -43,979,000USD | -26,284,000USD | -27,016,000USD | -27,561,000USD |
| Investments | 4,529,000USD | -162,184,000USD | 17,273,000USD | 34,234,000USD | -45,083,000USD | -114,424,000USD | 45,920,000USD | -4,878,000USD |
| Total Cashflows From Investing Activities | 4,529,000USD | -162,184,000USD | 17,273,000USD | 34,234,000USD | -45,083,000USD | -114,424,000USD | 45,920,000USD | -4,878,000USD |
| Total Cash From Financing Activities | 45,704,000USD | 213,552,000USD | 41,000USD | -2,518,000USD | 222,000USD | 244,300,000USD | 92,000USD | 15,605,000USD |
| Issuance Of Capital Stock | 41,918,000USD | 205,390,000USD | 0USD | 0USD | 0USD | 243,501,000USD | 0USD | 14,886,000USD |
| Change In Cash | 4,246,000USD | 13,041,000USD | -17,213,000USD | 1,833,000USD | -88,840,000USD | 103,592,000USD | 18,996,000USD | -16,828,000USD |
| Begin Period Cash Flow | 48,301,000USD | 35,260,000USD | 52,473,000USD | 50,640,000USD | 139,480,000USD | 35,888,000USD | 16,892,000USD | 33,720,000USD |
| End Period Cash Flow | 52,547,000USD | 48,301,000USD | 35,260,000USD | 52,473,000USD | 50,640,000USD | 139,480,000USD | 35,888,000USD | 16,892,000USD |
| Other Cashflows From Financing Activities | -4,407,000USD | 213,552,000USD | 41,000USD | -2,518,000USD | 222,000USD | 799,000USD | 92,000USD | 719,000USD |
| Unclassified Operating Cash Flow | -10,148,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 8,193,000USD | — | — | — | — | — | — | — |
| Net Borrowings | — | 0USD | 0USD | — | — | — | 0USD | — |
| Sale Purchase Of Stock | — | 282,000USD | — | 748,000USD | — | — | 650,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | -159,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -162,451,000USD | -129,474,000USD | -96,655,000USD | -104,787,000USD | -71,096,000USD | -22,121,000USD | -4,316,000USD | -2,197,000USD |
| Depreciation | 490,000USD | 393,000USD | 377,000USD | 1,658,000USD | 1,663,000USD | 11,000USD | 9,033USD | 8,000USD |
| Stock Based Compensation | 17,586,000USD | 22,582,000USD | 17,256,000USD | 18,829,000USD | 15,913,000USD | 3,108,000USD | 0USD | 1,000USD |
| Other Non Cash Items | -5,116,000USD | -7,016,000USD | -4,116,000USD | 18,042,000USD | 15,913,000USD | 641,000USD | -33USD | 122,000USD |
| Change In Working Capital | 2,775,000USD | 9,164,000USD | -589,000USD | 3,022,000USD | 2,830,000USD | -1,505,000USD | 1,226,000USD | -110,000USD |
| Total Cash From Operating Activities | -146,716,000USD | -104,351,000USD | -83,727,000USD | -82,065,000USD | -50,690,000USD | -19,866,000USD | -3,081,000USD | -2,176,000USD |
| Capital Expenditures | 0USD | -159,000USD | 0USD | -363,000USD | -1,575,000USD | -56,000USD | -56,000USD | -56,000USD |
| Free Cash Flow | -146,716,000USD | -104,510,000USD | -83,727,000USD | -82,428,000USD | -52,265,000USD | -19,922,000USD | -3,081,000USD | -2,176,000USD |
| Investments | -155,760,000USD | -93,526,000USD | 42,400,000USD | 91,842,000USD | -273,863,000USD | -56,000USD | -273,863,000USD | -273,863,000USD |
| Total Cashflows From Investing Activities | -155,760,000USD | -93,526,000USD | -4,851,000USD | 91,479,000USD | -275,438,000USD | -56,000USD | -56,000USD | -56,000USD |
| Net Borrowings | 3,000,000USD | 0USD | — | — | 0USD | 3,088,000USD | 3,088,000USD | 323,000USD |
| Total Cash From Financing Activities | 211,297,000USD | 268,818,000USD | 133,415,000USD | 476,000USD | 1,391,000USD | 358,403,000USD | 358,403,000USD | 5,254,000USD |
| Sale Purchase Of Stock | 1,030,000USD | — | — | 476,000USD | 1,391,000USD | -2,289,000USD | 0USD | 0USD |
| Issuance Of Capital Stock | 205,390,000USD | 266,288,000USD | 129,736,000USD | 0USD | 218,899,000USD | 356,963,000USD | 0USD | 4,931,000USD |
| Change In Cash | -91,179,000USD | 70,941,000USD | 44,837,000USD | 9,890,000USD | -324,737,000USD | 338,481,000USD | -3,081,000USD | 3,078,000USD |
| Begin Period Cash Flow | 139,480,000USD | 68,539,000USD | 23,702,000USD | 13,812,000USD | 338,549,000USD | 68,000USD | 3,149,000USD | 71,000USD |
| End Period Cash Flow | 48,301,000USD | 139,480,000USD | 68,539,000USD | 23,702,000USD | 13,812,000USD | 338,549,000USD | 68,000USD | 3,149,000USD |
| Other Cashflows From Financing Activities | 211,297,000USD | 2,530,000USD | 3,679,000USD | 476,000USD | 1,391,000USD | 134,765,000USD | — | 9,862,000USD |
| Unclassified Financing Cash Flow | -4,030,000USD | — | — | — | -1,391,000USD | 225,927,000USD | 355,315,000USD | -4,931,000USD |
| Other Cashflows From Investing Activities | — | -159,000USD | 14,000USD | -363,000USD | -1,575,000USD | -56,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | -47,265,000USD | — | — | — | 273,863,000USD | 273,863,000USD |
| Change To Liabilities | — | — | — | 7,369,000USD | -683,000USD | -220,000USD | 810,000USD | -100,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 9,890,000USD | -324,737,000USD | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | -18,829,000USD | -15,913,000USD | — | — | — |
| Dividends Paid | — | — | — | — | — | -3,088,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.